OMEROS CORP (OMER) Pre-Tax Margin
- 2026-06-30: Pre-Tax Margin 23.37%.
- 2026-03-31: Pre-Tax Margin 518.61%.
- 2021-09-30: Pre-Tax Margin -75.67%.
- 2020-12-31: Pre-Tax Margin -825.31%.
Complete source-backed pre-tax margin history.
- Available history
- 2016-12-31 to 2026-06-30
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2026-06-30 | 23.37% |
| 2026-03-31 | 518.61% |
| 2021-09-30 | -75.67% |
| 2020-12-31 | -825.31% |
| 2020-09-30 | -177.36% |
| 2019-12-31 | -334.81% |
| 2019-09-30 | -55.14% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2020-12-31 | -266.06% |
| 2019-12-31 | -149.49% |
| 2018-12-31 | -467.68% |
| 2017-12-31 | -82.50% |
| 2016-12-31 | -160.38% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |